After fast-tracking the entry of foreign vaccines, the government is now taking steps to increase the production of indigenously developed Covaxin by almost ten-fold by September. The move comes at a time when Covid-19 cases have surged across the country and several states have raised concern over vaccine shortage. According to the plan, the production of Covaxin will increase from the current 10 million doses per month to 60-70 million by July-August. By September, the production capacity is estimated to touch 100 million doses as Bharat Biotech along with three public sector enterprises would together manufacture Covaxin, the Centre said on Thursday. The Centre would provide at least Rs 130 crore as grant to two facilities under the Atmanirbhar Bharat 3.0 Mission Covid Suraksha for capacity augmentation. While financial support will be provided to two other companies for producing Covaxin, the quantum of funding is not known for them.
COVID-19: Mumbai s Haffkine Institute granted permission to produce Covaxin
COVID-19: Mumbai s Haffkine Institute granted permission to produce Covaxin
Mumbai: In a significant development, the Centre has allowed the Haffkine Bio-Pharmaceutical Corporation to produce Covaxin following technology transfer from the Hyderabad-based Bharat Biotech Corporation. The Department of Science and Technology has accepted the state governmentâs request made last month. The Centreâs permission to Haffkine to produce Covaxin is for one year, in view of the rising Covid cases.
Haffkine is soon expected to embark on vaccine production, putting experienced and trained scientists on the job.
Chief Minister Uddhav Thackeray has thanked Prime Minister Narendra Modi and indicated that the vaccine production can start in the state at a higher scale.
Who Is Dr Sumathy K: Star scientist whose role in Covaxin s development is unmissable ibtimes.co.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ibtimes.co.in Daily Mail and Mail on Sunday newspapers.
Covaxin is a COVID-19 vaccine developed and produced by Hyderabad-based Bharat Biotech (File)
Jaipur:
320 doses of Covaxin - Bharat Biotech s coronavirus vaccine - have been reported missing from a cold-storage facility at a government hospital in Rajasthan s Jaipur.
The HB Kanwatia Hospital, which caters primarily to the nearby working-class neighbourhood of Shastri Nagar, said its stock of 200 doses was checked and accounted for on Sunday.
The following day - Monday - a shipment of 489 doses was received. However, when stocks were re-checked the hospital found 320 doses were missing.
Security guards were posted outside the cold storage unit in which the vaccines were stored.
When India, The Pharmacy Of The World, Needs Prescriptions ndtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ndtv.com Daily Mail and Mail on Sunday newspapers.